Post by Idorsia Pharmaceuticals Ltd

Insomnia disorder affects millions of people across the world – yet it remains under-recognized and undertreated in many healthcare systems. Current pathways for evaluation and management are suboptimal, leaving far too many people without diagnosis or access to appropriate care. A recently published position paper in Sleep Medicine calls for change. Authored by leading European and Canadian specialists, the paper makes a clear and urgent case: insomnia disorder must be recognized as a chronic condition and prioritized in public health agendas. In this new article, Antonio Olivieri, Head of Global Medical Affairs, speaks with four co-authors of the paper – Prof. Luigi Ferini Strambi, Prof. Markku Partinen, Dr. Atul Khullar, and Prof. Eduard Vieta about why insomnia disorder demands greater recognition – not only as a condition experienced at night, but as a serious medical disorder with profound implications on daytime functioning, mental and physical health, and healthcare systems worldwide. We invite you to read the full discussion below.